Classification of lymphoid Neoplasms And Past



WHO-klassificeringen i 2008 af lymfoide neoplasmer og fortid: ideer under udvikling og fornuftige formål

 

Verdenssundhedsorganisationens klassificering af lymfoide neoplasmer opdateret i 2008 repræsenterer en verdensomspændende enighed om diagnosen af ​​disse tumorer og er baseret på anerkendelsen af ​​forskellige sygdomme ved hjælp af en tværfaglig tilgang. Den opdaterede klassificering forbedrede definitionerne af velkendte sygdomme, identificerede nye enheder og varianter og inkorporerede nye begreber i forståelsen af ​​lymfoide neoplasmer.

  • Nogle spørgsmål var imidlertid uafviklede, såsom i hvilket omfang specifikke genetiske eller molekylære ændringer definerer visse tumorer, og standing som foreløbige enheder, kategorier, som arbejdsgrupperne fra Verdenssundhedsorganisationen mente, at der ikke var tilstrækkelig bevis til at anerkende som forskellige sygdomme ved dette tid.
  • Derudover er der siden offentliggørelsen blevet genereret nye fund og ideer. Denne gennemgang opsummerer den videnskabelige begrundelse for klassificeringen og understregede ændringer, der har haft effekt på praksisretningslinjerne.
  • Forfatterne adresserer kriterierne og betydningen af ​​tidlige eller forløberlæsioner og identificeringen af ​​visse lymfoide neoplasmer, der stort set er forbundet med bestemte aldersgrupper, såsom børn og ældre.
  • Spørgsmålet om grænsekategorier, der har overlappende funktioner med retailer B-celle lymfomer, samt flere midlertidige enheder, gennemgås. Disse nye observationer kortlægger et kursus for fremtidig forskning på området.

 

 

Recombinant T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

4-RPB709Ra01
  • EUR 623.20
  • EUR 290.40
  • EUR 2006.98
  • EUR 748.99
  • EUR 1377.98
  • EUR 492.00
  • EUR 4837.44
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat T-Cell Leukemia/Lymphoma Protein 1A expressed in: E.coli

TCL1A T-cell Leukemia/Lymphoma 1A Human Recombinant Protein

PROTP56279 Regular: 50ug
EUR 380.4
Description: TCL1A Human Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 114 amino acids (1-114 a.a.) and having a molecular mass of 13.4kDa.;The TCL1A is purified by proprietary chromatographic techniques.

Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Protein

20-abx069248
  • EUR 811.20
  • EUR 343.20
  • EUR 2498.40
  • EUR 961.20
  • EUR 577.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Antibody

20-abx103881
  • EUR 493.20
  • EUR 159.60
  • EUR 1378.80
  • EUR 678.00
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

20-abx103882
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

20-abx000786
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

abx433350-200ul 200 ul
EUR 460.8

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

20-abx313149
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

abx218926-100ug 100 ug
EUR 526.8

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

abx224110-100ug 100 ug
EUR 493.2

T-Cell Leukemia/lymphoma Protein 1A (TCL1A) Antibody

abx238559-100ug 100 ug
EUR 661.2

Human T-cell leukemia/lymphoma protein 1A (TCL1A) ELISA Kit

abx518206-96tests 96 tests
EUR 801.6

Human TCL1A/ T-cell leukemia/lymphoma protein 1A ELISA Kit

E2460Hu 1 Kit
EUR 685.2

Human T- cell leukemia/lymphoma protein 1A, TCL1A ELISA KIT

ELI-05546h 96 Tests
EUR 988.8

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human)

4-PAB709Hu01
  • EUR 286.80
  • EUR 2869.20
  • EUR 717.60
  • EUR 358.80
  • EUR 253.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A)

Human T-Cell Leukemia/Lymphoma Protein 1A(TCL1A)ELISA Kit

QY-E04512 96T
EUR 433.2

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), APC

4-PAB709Hu01-APC
  • EUR 399.60
  • EUR 3735.60
  • EUR 1046.40
  • EUR 507.60
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with APC.

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), Biotinylated

4-PAB709Hu01-Biotin
  • EUR 363.60
  • EUR 2809.20
  • EUR 836.40
  • EUR 442.80
  • EUR 259.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with Biotin.

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), Cy3

4-PAB709Hu01-Cy3
  • EUR 483.60
  • EUR 4930.80
  • EUR 1345.20
  • EUR 627.60
  • EUR 294.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with Cy3.

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), FITC

4-PAB709Hu01-FITC
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with FITC.

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), HRP

4-PAB709Hu01-HRP
  • EUR 366.00
  • EUR 3256.80
  • EUR 926.40
  • EUR 459.60
  • EUR 243.60
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with HRP.

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), PE

4-PAB709Hu01-PE
  • EUR 344.40
  • EUR 3012.00
  • EUR 860.40
  • EUR 430.80
  • EUR 230.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with PE.

Mouse T-cell leukemia/lymphoma protein 1A (TCL1A) ELISA Kit

abx518207-96tests 96 tests
EUR 801.6

Mouse T- cell leukemia/lymphoma protein 1A, Tcl1a ELISA KIT

ELI-05545m 96 Tests
EUR 1038

T-Cell Leukemia/Lymphoma Protein 1A (TCL1A) Polyclonal Antibody (Human), APC-Cy7

4-PAB709Hu01-APC-Cy7
  • EUR 656.40
  • EUR 7327.20
  • EUR 1948.80
  • EUR 872.40
  • EUR 372.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human T-Cell Leukemia/Lymphoma Protein 1A (TCL1A). This antibody is labeled with APC-Cy7.

Recombinant human T-cell leukemia/lymphoma protein 1B

P1275 100ug Ask for price
Description: Recombinant protein for human T-cell leukemia/lymphoma protein 1B

TCL1B T-cell Leukemia/Lymphoma 1B Human Recombinant Protein

PROTO95988 Regular: 20ug
EUR 380.4
Description: TCL1B Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 151 amino acids (1-128a.a) and having a molecular mass of 17.2kDa. TCL1B is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

T-cell Leukemia / Lymphoma 1B Protein

20-abx261196
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 20 ug
  • 5 ug

CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size

CBA-135-T 24 assays
EUR 518.4
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis.

CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size

CBA-140-T 24 assays
EUR 547.2
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis.

Human EL4 (T lymphocite, Lymphoma) lysate

HCL-1287 100ug
EUR 285.6

CytoSelect 24-Well Cell Migration Assay (8 µm, Colorimetric Format), Trial Size

CBA-100-T 4 assays
EUR 358.8
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines.

CytoSelect 24-Well Cell Migration Assay (8 µm, Fluorometric Format), Trial Size

CBA-101-T 4 assays
EUR 358.8
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 8 µm pore size is suitable for most cell types including epithelial cells, fibroblasts, and cancer cell lines.

CytoSelect 24-Well Cell Migration Assay (5 µm, Fluorometric Format), Trial Size

CBA-102-T 4 assays
EUR 358.8
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 5 µm pore size is ideal for monocytes / macrophages.

CytoSelect 24-Well Cell Migration Assay (3 µm, Fluorometric Format), Trial Size

CBA-103-T 4 assays
EUR 358.8
Description: Chemotaxis describes the movement of cells toward or away from a chemical stimulus in their environment. Cell chemotaxis plays a pivotal role in the progression of cancer and other diseases. CytoSelect Cell Migration Assays are ideal for determining the chemotactic properties of cells. The 3 µm pore size is best for the smallest cells including neutrophils and other leukocytes.

CytoSelect 24-Well Cell Invasion Assay (Basement Membrane, Colorimetric Format), Trial Size

CBA-110-T 4 assays
EUR 386.4
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells.

CytoSelect 24-Well Cell Invasion Assay (Basement Membrane, Fluorometric Format), Trial Size

CBA-111-T 4 assays
EUR 386.4
Description: The ability of malignant tumor cells to invade normal surrounding tissue contributes in large part to the morbidity and mortality of cancers. Cell invasion requires several distinct cellular functions including adhesion, motility, detachment, and extracellular matrix proteolysis. Our CytoSelect Cell Invasion Assays utilize precoated inserts to assay the invasive properties of tumor cells. Invasive cells can be quantified in 24-well plates on either a standard microplate reader or a fluorescence plate reader. Inserts are precoated on the top of the membrane with ECM matrix gel (basement membrane), a protein mix isolated from EHS tumor cells.

CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation), Trial Size

CBA-130-T 24 assays
EUR 463.2
Description: Our CytoSelect 96-Well Cell Transformation Assay (Soft Agar Colony Formation) is suitable for measuring cell transformation where no downstream analysis is required. Cells are incubated in a semisolid agar medium for 7-8 days. The cells are then solubilized, lysed and detected using the included fluorescent dye in a fluorometric plate reader.

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC941259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF594 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCA1259-250 250uL
EUR 459.6
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), APC conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCAP1259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC611259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF660R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUM1259-50 50uL
EUR 474
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), 1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCP1259-250 250uL
EUR 459.6
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), PerCP conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCR1259-250 250uL
EUR 459.6
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), RPE conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-100 100uL
EUR 250.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNUB1259-500 500uL
EUR 549.6
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Concentration: 0.2mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC431259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF543 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC051259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405M conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC401259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF640R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC811259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680R conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC881259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF488A conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC801259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF680 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCH1259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC041259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF405S conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC681259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF568 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC701259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF770 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC551259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF555 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNCB1259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), Biotin conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-100 100uL
EUR 238.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

Granzyme B (NK/T-Cell Lymphoma Marker) Antibody

BNC471259-500 500uL
EUR 652.8
Description: Primary antibody against Granzyme B (NK/T-Cell Lymphoma Marker), CF647 conjugate, Concentration: 0.1mg/mL

T-cell leukemia/lymphoma 6 (TCL6) polyclonal antibody

ABP-PAB-02383 100 ug Ask for price

T-cell lymphoma, 75 cases (1.1mm), set 3

LYM1503 1
EUR 354
Description: Lymphoma tissue array, set 3, T-cell lymphoma, 150 cores from reactive lymphoid tissues (5 cases) and various T-cell lymphoma (68 cases) tissues in duplicates. IHC data include CD3, CD20, CD15, CD20, bcl2 et al.

Værtsbakterielle interaktioner i Helicobacter pylori-infektion.

Helicobacter pylori er spiralformede gramnegative bakterier med polær flagella, der lever nær overfladen af ​​den humane gastriske slimhinde. De har udviklet komplicerede mekanismer til at undgå bakteriedræbende syre i gastrisk lumen og for at overleve i nærheden, at binde sig til og kommunikere med det humane gastriske epitel og værtsimmunsystem.

Denne interaktion resulterer undertiden i svær gastrisk patologi. H pylori-infektion er den stærkeste kendte risikofaktor for udvikling af gastroduodenalsår, idet infektion er til stede i 60% -80% gastrisk og 95% af duodenalsår. (1) H pylori er også den første bakterie, der klassificeres som en bestemt kræftfremkaldende stof af Verdenssundhedsorganisationens internationale agentur for kræftforskning på grund af dets epidemiologiske forhold til gastrisk adenocarcinom og gastrisk slimhinde-associeret lymfoide vævslymfom.

(2) I de sidste 25 år, siden H pylori først blev beskrevet og dyrket, blev en komplet Der er sket paradigmeskift i vores kliniske tilgang til disse gastriske sygdomme, og mere finish 20.000 videnskabelige publikationer har vist sig om emnet.

Fra det medicinske synspunkt er H pylori et formidabelt patogen, der er ansvarligt for meget sygelighed og dødelighed i hele verden. Imidlertid forekommer H pylori-infektion i cirka halvdelen af ​​verdens befolkning, hvor sygdom er en undtagelse snarere finish reglen. At forstå, hvordan denne organisme interagerer med sin vært, er essentiel for at formulere en clever strategi til håndtering af dens vigtigste kliniske konsekvenser. Denne gennemgang giver et indblik i H pylori-værtsbakterielle interaktioner.

Fremskridt og løfte om FDG-PET-billeddannelse til kræftpasienthåndtering og onkologisk lægemiddeludvikling.

2 – [(18) F] Fluoro-2-deoxyglucose-positronemissionstomografi (FDG-PET) vurderer en grundlæggende egenskab ved neoplasi, Warburg-effekten. Denne molekylære billeddannelsesteknik tilbyder en komplementær tilgang til anatomisk billeddannelse, der er mere følsom og specifik i visse kræftformer.

 

FDG-PET er blevet anvendt i vid udstrækning inden for onkologi primært som et iscenesættelses- og genoprettelsesværktøj, der kan vejlede patientpleje. Fordi den nøjagtigt detekterer tilbagevendende eller resterende sygdom, har FDG-PET også et betydeligt potentiale til vurdering af terapirespons. I denne forbindelse kan det forbedre patienthåndtering ved at identificere respondenter tidligt, inden tumorstørrelse reduceres; ikke-svar kan ophøre med meningsløs behandling.

  • Endvidere korrelerer en reduktion i FDG-PET-signalet inden for dage eller uger efter påbegyndelse af terapi (for eksempel ved lymfom, ikke-lillecellet lunge og spiserørskræft) signifikant sammenhæng med langvarig overlevelse og andre kliniske slutpunkter, der nu anvendes i lægemiddelgodkendelser.
  • Disse fund antyder, at FDG-PET kunne lette lægemiddeludvikling som et tidligt surrogat med klinisk fordel. Denne artikel gennemgår det videnskabelige grundlag for FDG-PET og dens udvikling og anvendelse som et værdifuldt værktøj til billedbehandling af onkologi.
  • Dets potentiale til at lette lægemiddeludvikling i syv onkologiske omgivelser (lunge, lymfom, bryst, prostata, sarkom, kolorektal og æggestokk) behandles.
  • Anbefalinger inkluderer preliminary validering mod godkendte behandlingsformer, retrospektive analyser til at definere størrelsen af ​​ændringer, der indikerer respons, yderligere prospektiv validering som et surrogat med klinisk fordel, og anvendelse som et fase II / III-forsøgsendepunkt for at fremskynde evaluering og godkendelse af nye regimer og behandlingsformer.

 

 

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04520 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH1

7-04521 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04522 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04523 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH2

7-04524 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04525 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04526 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH3

7-04527 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04528 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04529 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -BH4

7-04530 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04537 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04538 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 -NWGR

7-04539 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04543 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04544 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL

7-04545 1mg Ask for price

B-Cell Leukemia/Lymphoma 2

PR27249 5 ug
EUR 229.2

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-48T 48T
EUR 591.6
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

DLR-Bcl2-b-96T 96T
EUR 769.2
Description: A sandwich quantitative ELISA assay kit for detection of Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) in samples from serum, plasma, tissue homogenates or other biological fluids.

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RDR-Bcl2-b-48Tests 48 Tests
EUR 619.2

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RDR-Bcl2-b-96Tests 96 Tests
EUR 859.2

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RD-Bcl2-b-48Tests 48 Tests
EUR 592.8

Bovine B-Cell Leukemia/Lymphoma 2 (Bcl2) ELISA Kit

RD-Bcl2-b-96Tests 96 Tests
EUR 820.8

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Hu01
  • EUR 442.56
  • EUR 242.40
  • EUR 1329.60
  • EUR 523.20
  • EUR 926.40
  • EUR 372.00
  • EUR 3144.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Mu01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

Recombinant B-Cell Leukemia/Lymphoma 2 (Bcl2)

4-RPA778Ra01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat B-Cell Leukemia/Lymphoma 2 expressed in: E.coli

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04549 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04550 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 His Tag

7-04551 1mg Ask for price

BCL2 B-Cell Leukemia/Lymphoma 2 Human Recombinant Protein

PROTP10415-7 Regular: 20ug
EUR 380.4
Description: Recombinant Human BCL2 produced in E.coli cells is a non-glycosylated, homodimeric protein containing 210 amino acid chain and having a molecular mass of 23.2kDa. The Human BCL2 is purified by proprietary chromatographic techniques.

anti-Bcl-2(B cell lymphoma 2)

LF-PA0178 100 ul
EUR 400.8
Description: Rabbit polyclonal to Bcl-2(B cell lymphoma 2)

Recombinant human B-cell lymphoma 6 protein

P1281 100ug Ask for price
Description: Recombinant protein for human B-cell lymphoma 6 protein

Recombinant Human B-cell CLL/lymphoma 6

RP-901 2 ug
EUR 416.4

Bcl-2 B-Cell Leukemia/Lymphoma 2 Human Recombinant Protein (-BH4)

PROTP10415 Regular: 10ug
EUR 380.4
Description: Bcl-2 Des BH4 domain (10-30 residues) Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 197 amino acids 1-9 and 31-218.;The Bcl-2 is expressed as His-Tag fusion protein and purified by proprietary chromatographic techniques.

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04531 5µg Ask for price

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04532 20µg Ask for price

Recombinant Human B-Cell Lymphoma Protein 2 Alpha, His Tag

7-04533 1mg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04546 2µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04547 10µg Ask for price

Recombinant Human B-Cell Leukemia/Lymphoma 2 XL GST Tag

7-04548 1mg Ask for price

Human B-Cell Leukemia/Lymphoma 2 (Bcl2) Protein

20-abx065513
  • EUR 627.60
  • EUR 292.80
  • EUR 1796.40
  • EUR 727.20
  • EUR 460.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)

4-RPL251Ca01
  • EUR 640.39
  • EUR 295.20
  • EUR 2071.49
  • EUR 770.50
  • EUR 1420.99
  • EUR 504.00
  • EUR 4998.72
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Dog B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)

4-RPL251Hu01
  • EUR 496.32
  • EUR 256.80
  • EUR 1531.20
  • EUR 590.40
  • EUR 1060.80
  • EUR 408.00
  • EUR 3648.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein 2 (Bcl2L2)

4-RPL251Mu01
  • EUR 582.34
  • EUR 279.60
  • EUR 1853.76
  • EUR 697.92
  • EUR 1275.84
  • EUR 465.60
  • EUR 4454.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein 2 expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)

4-RPE582Hu01
  • EUR 442.56
  • EUR 242.40
  • EUR 1329.60
  • EUR 523.20
  • EUR 926.40
  • EUR 372.00
  • EUR 3144.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)

4-RPE582Mu01
  • EUR 421.06
  • EUR 236.40
  • EUR 1248.96
  • EUR 496.32
  • EUR 872.64
  • EUR 357.60
  • EUR 2942.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

Recombinant B-Cell CLL/Lymphoma 2 Like Protein (Bcl2L)

4-RPE582Ra01
  • EUR 528.58
  • EUR 265.20
  • EUR 1652.16
  • EUR 630.72
  • EUR 1141.44
  • EUR 429.60
  • EUR 3950.40
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Rat B-Cell CLL/Lymphoma 2 Like Protein expressed in: E.coli

B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody

abx019019-100ug 100 ug
EUR 410.4

B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody

abx413147-01mg 0.1 mg
EUR 526.8

B-Cell Leukemia/Lymphoma 2 (Bcl-2) Antibody

abx448522-100ug 100 ug
EUR 627.6

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx102594
  • EUR 477.60
  • EUR 159.60
  • EUR 1328.40
  • EUR 644.40
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx102595
  • EUR 493.20
  • EUR 159.60
  • EUR 1362.00
  • EUR 661.20
  • EUR 376.80
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx109553
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx171393
  • EUR 376.80
  • EUR 944.40
  • EUR 493.20
  • EUR 184.80
  • EUR 309.60
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx171394
  • EUR 1011.60
  • EUR 526.80
  • 1 mg
  • 200 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx171395
  • EUR 1095.60
  • EUR 560.40
  • 1 mg
  • 200 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx175544
  • EUR 1362.00
  • EUR 661.20
  • 1 mg
  • 200 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx175545
  • EUR 510.00
  • EUR 159.60
  • EUR 1412.40
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx175546
  • EUR 1545.60
  • EUR 744.00
  • 1 mg
  • 200 ug

B-Cell Leukemia/Lymphoma 2 (Bcl2) Antibody

20-abx175547
  • EUR 1545.60
  • EUR 744.00
  • 1 mg
  • 200 ug

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx148562-100ug 100 ug
EUR 526.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx121300
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx121846
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx125557
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx125558
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx133877
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx136153
  • EUR 594.00
  • EUR 427.20
  • 100 ul
  • 50 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx137363
  • EUR 844.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 20 ug
  • 5 ug

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx139065-01mg 0.1 mg
EUR 460.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx111191
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx000596
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx016080-100ul 100 ul
EUR 493.2

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx018050-100ug 100 ug
EUR 460.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx019021-100ug 100 ug
EUR 410.4

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx020100-100ug 100 ug
EUR 526.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx012118-100ug 100 ug
EUR 526.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx012120-100ug 100 ug
EUR 526.8

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

20-abx009552
  • EUR 360.00
  • EUR 526.80
  • EUR 226.80
  • 100 ul
  • 200 ul
  • 30 ul

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx038146-100ug 100 ug
EUR 469.2

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx027629-400ul 400 ul
EUR 627.6

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx027629-80l 80 µl
EUR 343.2

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx034669-400ul 400 ul
EUR 627.6

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx034669-80l 80 µl
EUR 343.2

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx031085-400ul 400 ul
EUR 627.6

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx031085-80l 80 µl
EUR 343.2

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx031231-400ul 400 ul
EUR 627.6

B-Cell Leukemia/Lymphoma 2 (BCL2) Antibody

abx031231-80l 80 µl
EUR 343.2

Leave a Reply

Din e-mailadresse vil ikke blive publiceret.